Omeprazole Sandoz Conseil

Omeprazole, the active ingredient in Omeprazole Sandoz Conseil, is a proton pump inhibitor presented as a 20 mg tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease, peptic ulcer disease and Zollinger‑Ellison syndrome in adults.

GNH USA supplies Omeprazole Sandoz Conseil as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Omeprazole Sandoz Conseil is a proton pump inhibitor that acts on the gastric acid secretion pathway. It is indicated for several acid‑related gastrointestinal conditions: - Gastro‑oesophageal reflux disease (GERD): provides symptomatic relief and promotes healing of the oesophageal lining. - Peptic ulcer disease: supports ulcer healing by maintaining a low‑acid environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with this rare endocrine disorder. - NSAID‑induced ulcer prophylaxis: reduces the risk of ulcer formation in patients regularly using non‑steroidal anti‑inflammatory drugs.

Adverse reactions to omeprazole are generally mild but can vary in frequency.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: sudden kidney inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reactions. - Hepatic injury: elevated liver enzymes or hepatitis. - Fracture risk: possible reduction in bone mineral density with long‑term use.

When using Omeprazole Sandoz Conseil, consider the following safety measures: - Assess renal function: adjust use in patients with severe impairment. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Monitor long‑term therapy: evaluate need for continued treatment after 12 months. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Elderly patients: start with the lowest effective dose and monitor for adverse effects. - Store at ambient temperature: keep below 25 °C, retain original packaging, and protect from moisture.

Omeprazole may interact with several medicines, requiring attention to avoid reduced efficacy or increased toxicity.

Major Interactions (Avoid): - Clopidogrel: omeprazole reduces its antiplatelet activation. - Atazanavir: decreased absorption leading to therapeutic failure. - Dasatinib: lowered plasma concentrations.

Moderate Interactions (Monitor Closely): - Warfarin: potential increase in INR values. - Methotrexate: reduced renal clearance may raise toxicity. - Digoxin: higher serum levels reported. - Phenytoin: enhanced metabolism decreasing seizure control.